INFA Price Prediction Next Week
Analysis and Insights
News Impact:
Informatica Inc. (INFA) has recently faced significant analyst downgrades from firms like Baird and Wells Fargo, with price targets reduced to $19 from $35 and $34, respectively. This downgrade reflects a bearish sentiment among analysts, driven by the company's weaker-than-expected Q4 sales results and FY25 revenue guidance.
Technical Analysis:
The stock is currently trading at $18.63, near the lower end of its Fibonacci range, with a pivot point at $18.86. Key resistance levels are at $19.62 and $20.08, while support is at $17.64. The RSI is at 26, indicating oversold conditions, but the MACD remains negative, signaling continued downward momentum.
Fibonacci Levels:
The Fibonacci levels for INFA are as follows:
| Level | Price |
|---|---|
| R1 | $19.62 |
| R2 | $20.08 |
| R3 | $20.84 |
| Pivot | $18.86 |
| S1 | $17.64 |
| S2 | $16.88 |
| S3 | $16.38 |
Price Prediction:
Given the bearish news and technical indicators, INFA is expected to trade around $18.50 next week. While oversold conditions may lead to a minor bounce, the overall trend remains bearish.
Recommendation:
Sell or avoid INFA in the short term due to negative news and technical weakness.
INFA Similar Chart Price Prediction
The price of INFA is predicted to go up 3.01%, based on the high correlation periods with BW. The similarity of these two price pattern on the periods is 99.62%.
INFA
BW
Up: 3.01%Similarity: 99.62%
INFA Revenue Forecast
INFA EPS Forecast
INFA FAQs
What is INFA revenue forecast for next quarter？
What is INFA eps forecast for next quarter？
INFA Analyst's Forecast
Karl Keirstead
UBS
Hold
2025-02-14
Price Target
$30 → $19
Downside
-3.8%
UBS lowered the firm's price target on Informatica to $19 from $30 and keeps a Neutral rating on the shares. Informatica's Q4 print was weak and "perhaps" thesis-changing, marked notably by a total and cloud annual recurring revenue miss, a steep deceleration in 2025 cloud ARR growth, and total ARR guidance of 3% in constant currency, all of which comes against a demand backdrop that the company described as "stable" in Q4, the analyst tells investors in a research note. UBS says shares might be range bound with the prospect of returning to double-digit revenue and ARR growth off the table over the medium-term.
Andrew Nowinski
Wells Fargo
Buy → Hold
2025-02-14
Price Target
$34 → $19
Downside
-3.8%
William Power
Baird
Buy → Hold
2025-02-14
Price Target
$35 → $19
Downside
-3.8%
